Skip to content
anayah

Understanding the condition · 5 min read

What a low AMH actually measures

By Nyssa Desai · Published 17 September 2026

An AMH test is a blood test. The result is a single number, with a range beside it marking where low begins.

What AMH is

Anti-Müllerian Hormone is made by the small immature follicles sitting in the ovaries. The amount in the blood roughly tracks how many of them are left.

It is a headcount, though it does not measure the quality of those eggs, or whether any given month ends in a pregnancy.

Search for it and the names get bigger. Fertility test, egg count test, a way of reading your ovarian age. Those are marketing words for a headcount, and they are where most of the worry starts, usually long after the appointment has ended.

The range was not built on Indian women

Then there is the range printed beside the result. Somebody had to decide where it sits, and for one of the most widely used AMH tests, it was worked out on healthy women recruited in the Netherlands, Belgium, Germany, France and Turkey.

How much lower AMH runs in healthy Indian women than in healthy European women:

11.9%

lower at age 25

20%

lower across all ages

Gromski et al., Reproductive BioMedicine Online 2022, comparing 400 healthy women recruited from the community in Kolhapur with 758 healthy European women. The gap appears to widen with age. How much is not settled, so no figure for it is shown here.

Those are healthy women measured against healthy women. Four hundred recruited from the community in Kolhapur, against the seven hundred and fifty-eight European women whose results set that reference range in the first place. No fertility patients in either group. The authors are careful to say the Indian women were not tested for fertility, only that none of them had a known problem.

And every sample in both groups went through the same assay on the same equipment, so this is one measurement of two populations. It is not two published numbers being held up against each other.

So a number that looks low against a European range can be an ordinary number for an Indian woman the same age. What changes is the scale.

This is the same problem as BMI, where obesity starts at 25 in India and 30 under the WHO standard, and the same measurements get read two different ways.

The measurement at 45 is loose enough to include no gap at all, which is why no figure for it appears above. What holds up is a real difference through the twenties and thirties.

The research is also not unanimous. An earlier study at a UK fertility clinic found the difference between South Asian and European patients disappeared once other factors were accounted for. The Kolhapur authors set out why that study is hard to read across: everyone in it was attending a fertility clinic, around one in ten had had ovarian surgery, up to a quarter smoked, and rates of PCOS ran from 9% to 26% depending on ethnicity. Every one of those moves AMH.

Indian studies reporting worrying rates of low ovarian reserve in women under 35 come up often, and the same check applies. Those also counted women who had already come to a fertility clinic, a group selected for having difficulty in the first place. That says something real about clinic patients and very little about women in general.

Whether a low result changes the chance of conceiving

One study tested this directly. It followed 750 American women aged 30 to 44, most of them white and university educated, who had no history of infertility and had been trying to conceive for three months or less. It measured their AMH, then waited to see who got pregnant.

Women with a low AMH conceived at the same rate as women with a normal one. The shaded bars show the range each estimate could plausibly sit in, and they overlap almost completely.

Three things mark the limits of what that proves.

The low-AMH group was only 84 women, so the study could not find a difference. That is a weaker statement than showing there is none. For the same reason the authors say it was not powered to look at results at or below 0.1 ng/mL.

It measured pregnancy. Whether those pregnancies went on to a birth is a separate question, and the study did not follow it that far.

Everyone in it had no history of infertility, and had been trying for three months or less. For someone who has been trying for two years, AMH is being read alongside a great deal of other information, and this particular finding is not the one that applies.

And there is one exclusion that matters more than the rest for anyone reading this site. Women with PCOS were excluded from the study by design, alongside anyone who had had fertility treatment or a diagnosis of endometriosis. So the finding above is about women without those conditions, and it does not carry over to a woman with PMOS on its own.

Why a high number is more likely with PMOS

For women with PMOS, formerly called PCOS, the more common surprise is a number that reads high.

AMH comes from small follicles, and PMOS means more of them. In the Kolhapur study, the 220 women with PCOS had higher AMH than the healthy women from the same community, and the gap was widest under 30.

It is the same thing an ultrasound describes when it counts follicles, arriving by a different route. Nothing has gone wrong.

That study found something else worth keeping if the word infertility has been used about you. Among the 1,600 women attending the fertility clinic, AMH depended on why they were there. Where the cause was severe male factor, 95 women, AMH looked like the healthy group. Where it was unexplained, 757 women, it ran lower. There is no single AMH picture for infertility. The number tracks the underlying cause.

There is also no agreed cutoff for a high result, and no reason to read much into the exact number. A separate study of proven-fertile Indian women reports values well above the Kolhapur ones at the same ages, because it ran on a different assay. Two laboratories measuring the same sample can return different numbers, and neither is wrong.

An AMH number carries no meaning by itself. What it means depends on who is being measured, on what, and why.

What AMH predicts well

AMH predicts how ovaries will respond to stimulation. Before IVF, a doctor has to choose a drug dose, and AMH is a good guide to whether someone is likely to produce many eggs or few. Getting that dose right matters, and it is what the test was built for.

That is a question about planning a treatment. How much time somebody has is a different question, and one AMH was never designed to answer.

So the useful thing to ask about any result is which decision it is meant to inform. Your doctor ordered the test for a reason. Asking what that reason was will tell you more than the number does on its own.

Sources3 studies
  • Gromski PS, Patil RS, Chougule SM, Bhomkar DA, Jirge PR, Nelson SM. "Ethnic discordance in serum anti-Müllerian hormone in European and Indian healthy women and Indian infertile women." Reproductive BioMedicine Online. 2022. doi:10.1016/j.rbmo.2022.06.023 Three cohorts totalling 2,758 women: 758 healthy European, 400 healthy from a community cohort in Kolhapur, and 1,600 Indian infertility patients. The healthy-to-healthy comparison is the one used here. The European women were originally recruited to evaluate the Elecsys AMH assay and to determine its reference range, so that cohort is the reference range, and every sample in the study was measured on that same assay. The authors state the healthy women were not known to have proven fertility. AMH was 20.0% lower overall and 11.9% lower at age 25. The figure for age 45 is 40.0% lower, on an interval running from 0 to 64.6%, so it includes no gap at all and is kept off the page.
  • Steiner AZ, Pritchard D, Stanczyk FZ, et al. "Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age." JAMA. 2017;318(14):1367–1376. doi:10.1001/jama.2017.14588 750 women aged 30 to 44 with no history of infertility, 77% white and 62% holding a graduate degree, which is narrower than the general population. Low AMH was defined as under 0.7 ng/mL.
  • Malhotra N, Gupta P, Kamboj S, Chaturvedi P, Kutum R. "Age specific variations in ovarian reserves in healthy fertile and infertile women: A cross sectional study." PLOS ONE. 2024;19(10):e0308865. doi:10.1371/journal.pone.0308865 Age-specific values for proven-fertile Indian women at a single North Indian centre. Measured on a different assay from the Kolhapur study, which is why the two sets of numbers sit well apart and why neither is quoted here as a range to judge a result against.

Anayah is being built for women navigating PMOS, thyroid conditions and everything that comes after. If you would like to know when it is ready, join the waitlist. We will email you once, when there is something worth your time.

Anayah does not provide medical advice, diagnosis or treatment. Nothing here replaces a consultation with a qualified doctor.

Want to know when it's ready?

Tell us where you are and we'll come back to you before we build it.

Anayah's waitlist is for adults. If you're under 18 and something feels off, please talk to a parent, guardian, or doctor.